Home > Insider Trading > Filing (0001209191-18-051837)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628738	Audentes Therapeutics Inc.	BOLD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1401018	R Matthew Patterson	C/O Audentes Therapeutics, Inc. 600 California Street, 17Th Floor San Francisco CA 94108	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-18	12,952	$2.19	12,952	No	4	M	Direct
Common Stock	Disposition	2018-09-18	12,952	$40.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-09-18	12,952	$0.00	12,952	$2.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
128,345		2025-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	171,814	Indirect	By Matthew R. Patterson Revocable Trust

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The reporting person is the trustee of the Matthew R. Patterson Revocable Trust.
The option vested as to 25% of the total shares on February 4, 2016, and then 6.25% of the total shares will vest quarterly thereafter, with 100% of the total shares vested and exercisable on February 4, 2019, subject to the reporting person's provision of service to the issuer on each vesting date.